How to select older patients with acute myeloid leukemia fit for intensive treatment?

2020 ◽  
Author(s):  
Zuzana Sustkova ◽  
Lukas Semerad ◽  
Barbora Weinbergerova ◽  
Jiri Mayer
Keyword(s):  
Acute Myeloid Leukemia ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Intensive Treatment ◽  
Acute Myeloid

scholarly journals Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

Blood ◽  
2013 ◽  
Vol 122 (8) ◽  
pp. 1384-1394 ◽  
Author(s):  
Alan K. Burnett ◽  
Nigel H. Russell ◽  
Ann E. Hunter ◽  
Donald Milligan ◽  
Steven Knapper ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Low Dose ◽  
Response Rate ◽  
Intensive Treatment ◽  
Key Points ◽  
Remission Rates ◽  
Acute Myeloid

Key Points In older patients with AML who are not suitable for intensive treatment, clofarabine doubles remission rates Survival is not improved compared with low-dose Ara-C

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia

Leukemia ◽  
2016 ◽  
Vol 30 (7) ◽  
pp. 1485-1492 ◽  
Author(s):  
C-H Tsai ◽  
H-A Hou ◽  
J-L Tang ◽  
C-Y Liu ◽  
C-C Lin ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Genetic Alterations ◽  
Clinical Implications ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document